MediConnect has completed the workflow for a PoC designed to track medications through the supply chain.
Blockchain startup MediConnect has completed the workflow for the Proof-of-Concept (PoC) designed to track medications through the supply chain and begun integration of online pharmacy UK Meds’ processes to its platform.
Tracking medication through the supply chain
Per a press release shared with Cointelegraph on Sept. 26, MediConnect established a foundation and methodology for proof of concept finalization, which will enable tracking and managing of prescription medication through the supply chain — from manufacturer to end users.
In 2020, MediConnect is also planning to complete a pilot scheme, which includes up to 10 participants. As part of the pilot, MediConnect will integrate online pharmacy UK Meds’ processes into its blockchain-based platform, allowing thus to trace products through its supply chain and prevent the misuse of prescription medications.
Blockchain in healthcare
Earlier this year, the Ugandan government partnered with MediConnect to trace counterfeit drugs in the country. Similar to UK Meds’ case, the blockchain-based platform enables the recording of prescription medication, thus identifying counterfeit drugs and preventing their distribution in the pharmaceutical supply chain.
The potential of blockchain tech in the healthcare and supply chain sectors is recognized by other world’s governments and institutions. Most recently, the United Arab Emirates’ Ministry of Health and Prevention launched a blockchain system for recording and sharing healthcare data.
Tech startup Nebula Genomics rolled out anonymous genetic testing earlier in September, enabling clients to purchase whole genome sequencing and provide saliva samples without the need to share personal data such as their name, address or credit card number.
Source: , CoinTelegraph
Articles listed with Cash Tech News as the author are either general information, or may have been imported from another website, to bring our readers a rich media experience that encompasses articles that we find interesting, as well as those curated by others.
The views and opinions expressed here are for informational purposes only, and should not be confused with professional financial advice. These opinions are solely those of the author and do not necessarily reflect the views of CashTechNews.com. Every investment and trade involves risk. You should conduct your own research, and contact your professional financial advisor before making any investment.
Corrections, feedback, and ideas should be submitted through the website contact form.